VIA
INBX icon

Virtus Investment Advisers’s Inhibrx INBX Stock Holding History

Virtus Investment Advisers’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$230K Buy
3,425
+82
+2% +$6.08K 0.06% 323
2025
Q4 		$264K Buy
+3,343
New +$228K 0.07% 305

Other funds holding INBX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Virtus Investment Advisers's INBX Position: Q1 2026 in Review

Virtus Investment Advisers increased its Inhibrx (INBX) stake by 2.5% in Q1 2026, buying an estimated $6.08K and bringing the position to 3,425 shares worth $230K. The position accounts for 0.06% of the portfolio, ranked #323.

Virtus Investment Advisers first reported a position in INBX in Q4 2025 and has held it in 2 quarters since. The position peaked at $264K in Q4 2025. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Virtus Investment Advisers held 3,425 shares of Inhibrx worth $230K as of Q1 2026.
  • Virtus Investment Advisers bought 82 Inhibrx shares in Q1 2026, an estimated $6.08K.
  • Inhibrx made up 0.06% of Virtus Investment Advisers's portfolio in Q1 2026, its #323 holding.
  • Virtus Investment Advisers first reported a position in Inhibrx in Q4 2025 and has held it in 2 quarters since.
  • Virtus Investment Advisers's Inhibrx position peaked at $264K in Q4 2025.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Virtus Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.